20. Juli 2023
Published by Paul Wolfrom on 20. Juli 2023
Categories

LimmaTech Biologics Appoints Franz-Werner Haas as CEO to Lead Company into Next Stage of Corporate Growth

LimmaTech has leveraged a novel technology platform to produce a pipeline of vaccines against multi-resistant bacterial infections that present global health threats
Do you like it?0
Read more
Prev page
123456789101112131415
Next page